Cover Image
Market Research Report

North America Blood Market Forecast 2019-2028

Published by Inkwood Research Product code 952505
Published Content info 111 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Blood Market Forecast 2019-2028
Published: August 3, 2020 Content info: 111 Pages
Description

KEY FINDINGS

The North America blood market is anticipated to record a CAGR of 4.08%, during the forecast years of 2019 to 2028. Key factors influencing the market growth include stringent government regulations, the incidence of Chagas disease, and the rise in the adoption of advanced automated blood transfusion systems.

MARKET INSIGHTS

The North America blood market growth is assessed across Canada and the United States. As one of the safest blood systems, Canada's strict guidelines align with the standards set by Health Canada's Food and Drugs Act and Blood Regulations for obtaining blood and plasma. However, the plasma collected in the country is insufficient to fulfill the demand for plasma products. Besides, the majority of plasma products supplied by the Hema-Quebec and the Canadian Blood Services, are purchased from the United States manufacturers, and made from the nation's paid-donor plasma. As a result, plasma received from paid donors is required to meet Canada's demand for plasma products, which subsequently fuel the region's blood market.

Moreover, the increased prevalence of Chagas disease, owing to the immigration of infected persons from areas prone to the parasite, impacts market growth. The infection is primarily transmitted through the feces of blood-sucking bugs, congenital transmission, blood transfusion, organ transplantation, or the ingestion of contaminated foods. Additionally, acute, vector-borne infections are not severe, but may persist throughout the individual's lifetime, often without symptoms.

COMPETITIVE INSIGHTS

Some prominent companies in the market include, Abbott Laboratories, Bio-Rad Laboratories Inc, Haemonetics Corporation, Merck & Co Inc, Baxter International Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32912

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
    • 3.2.2. SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
    • 3.2.3. RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
    • 3.2.4. PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
    • 3.2.5. PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
    • 3.3.2. DEARTH OF SKILLED LABORATORY PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. IMPACT OF COVID - BLOOD MARKET

5. MARKET BY PRODUCT

  • 5.1. WHOLE BLOOD COLLECTION
    • 5.1.1. WHOLE BLOOD COLLECTION SYSTEMS
    • 5.1.2. WHOLE BLOOD COLLECTION REAGENTS
  • 5.2. SOURCE PLASMA COLLECTION
    • 5.2.1. SOURCE PLASMA COLLECTION SYSTEMS
    • 5.2.2. SOURCE PLASMA COLLECTION REAGENTS
  • 5.3. BLOOD THERAPEUTICS
    • 5.3.1. INTRAVENOUS IMMUNOGLOBULIN (IVIG)
    • 5.3.2. ALBUMIN
    • 5.3.3. HYPERIMMUNE
    • 5.3.4. FACTOR VIII
    • 5.3.5. FACTOR IX
    • 5.3.6. OTHER BLOOD THERAPEUTICS
  • 5.4. BLOOD TYPING
    • 5.4.1. BLOOD TYPING SYSTEMS
    • 5.4.2. BLOOD TYPING REAGENTS
  • 5.5. BLOOD SCREENING
    • 5.5.1. BLOOD SCREENING SYSTEMS
    • 5.5.2. BLOOD SCREENING REAGENTS
  • 5.6. BLOOD PROCESSING EQUIPMENT
    • 5.6.1. BLOOD PROCESSING EQUIPMENT SYSTEMS
    • 5.6.2. BLOOD PROCESSING EQUIPMENT REAGENTS

6. MARKET BY END-USER

  • 6.1. BLOOD & BLOOD COMPONENT BANKS
  • 6.2. DIAGNOSTIC LABORATORIES
  • 6.3. AMBULATORY SURGICAL CENTERS
  • 6.4. HOSPITALS
  • 6.5. OTHER END-USERS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. BIO-RAD LABORATORIES INC
  • 8.3. CSL LIMITED (CSL BEHRING)
  • 8.4. F HOFFMANN-LA ROCHE LTD
  • 8.5. GRIFOLS INTERNATIONAL SA
  • 8.6. HAEMONETICS CORPORATION
  • 8.7. MERCK & CO INC
  • 8.8. NOVO NORDISK A/S
  • 8.9. BAXTER INTERNATIONAL INC
  • 8.10. BECTON DICKINSON AND COMPANY
  • 8.11. FRESENIUS KABI AG
  • 8.12. ORTHO CLINICAL DIAGNOSTICS
  • 8.13. TERUMO CORPORATION (TERUMO BCT INC)
  • 8.14. IMMUCOR INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BLOOD
  • TABLE 2: NORTH AMERICA BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA BLOOD MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA BLOOD MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: NORTH AMERICA BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019
  • FIGURE 8: NORTH AMERICA BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019
  • FIGURE 12: NORTH AMERICA BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019
  • FIGURE 16: NORTH AMERICA BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 23: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019
  • FIGURE 24: NORTH AMERICA BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019
  • FIGURE 28: NORTH AMERICA BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: NORTH AMERICA BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 30: NORTH AMERICA BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 31: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019
  • FIGURE 32: NORTH AMERICA BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: NORTH AMERICA BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: NORTH AMERICA BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 35: NORTH AMERICA BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)
  • FIGURE 36: NORTH AMERICA BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)
  • FIGURE 37: NORTH AMERICA BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: NORTH AMERICA BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
  • FIGURE 39: NORTH AMERICA BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: NORTH AMERICA BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: UNITED STATES BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: CANADA BLOOD MARKET, 2019-2028 (IN $ MILLION)
Back to Top